Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,002,750
+$911,624 QoQ
Shares Held
113,104
+1.4% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#154
of 494 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $41,687,806 across 71 Biotechnology names. ROIV ranks #4 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
58,590 | $7,776,650 | |
| 2 | TECH |
BIO-TECHNE Corp
|
91,696 | $6,478,322 | |
| 3 | PGEN |
Precigen, Inc.
|
882,267 | $5,028,921 | |
| 4 | ROIV |
Roivant Sciences Ltd.
This page
|
113,104 | $4,002,750 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
10,997 | $2,059,518 | |
| 6 | QURE |
uniQure N.V.
|
32,229 | $1,484,467 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
215,239 | $828,670 | |
| 8 | CGON |
CG Oncology, Inc.
|
10,811 | $768,121 |
All Filings in ROIV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,002,750 | 113,104 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $3,091,126 | 111,593 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $2,615,175 | 120,515 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,226,740 | 81,080 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,857,070 | 164,780 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $2,669,814 | 264,600 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,897,640 | 244,940 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $3,163,921 | 274,170 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $2,772,278 | 262,278 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,811,608 | 266,756 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $204,397 | 18,201 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $260,230 | 22,280 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $496,944 | 49,300 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $301,104 | 40,800 | Shares | Other | 2023-06-01 | |
| 2022-12-31 | $168,589 | 21,100 | Shares | Other | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||